Home
  • About Exelixis
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Strategic Alliances
    • Community Involvement
    • Locations
    • Contact Us
  • Pipeline
    • Core Compounds
    • Out-Licensed Compounds
    • Partnering Compounds
  • Clinical Trials
    • Brain Cancer
    • Breast Cancer
    • Endometrial Cancer
    • Gastric Cancer
    • Hematologic Malignancies
    • Liver Cancer
    • Lung Cancer
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Skin Cancer
    • Thyroid Cancer
  • Investors and Media
    • Management and Board
    • Corporate Governance
    • Stock Information
    • Fundamentals
    • Analyst Coverage
    • Earnings Estimates
    • Earnings Ratings
    • Annual Reports
    • SEC Filings
    • Press Releases
    • Event Calendar
    • Information Request
    • Investor FAQs
    • Contact IR
  • Careers
    • Job Opportunities
    • Benefits
    • Events
    • Awards
  • Contact Us

Investors and Media

  • Management and Board
  • Corporate Governance
  • Stock Information
  • Fundamentals
  • Analyst Coverage
  • Earnings Estimates
  • Earnings Ratings
  • Annual Reports
  • SEC Filings
  • Press Releases
  • Event Calendar
  • Information Request
  • Investor FAQs
  • Contact IR
© Exelixis, Inc. 2010   Website design: Hane Chow, Inc.
  • Terms of Use